Related Experiment Videos
Angiographic considerations in patients undergoing liver-directed therapy
David M Liu1, Riad Salem, James T Bui
1Department of Radiology, Interventional Radiology Section, St. Vincent's Hospital, Portland, Oregon, USA.
Summary
Understanding liver arterial anatomy variations is crucial for optimizing liver-directed therapies. This review details normal anatomy, variants, and perfusion changes for safer, more effective treatments like intraarterial brachytherapy.
Area of Science:
- Interventional Radiology
- Vascular Anatomy
- Hepatobiliary Medicine
Background:
- Liver-directed therapies are advancing rapidly, necessitating a deeper understanding of hepatic arterial anatomy.
- The mesenteric system, especially the hepatic arterial bed, exhibits significant anatomical variation.
- Accurate presurgical planning, catheterization, and transarterial therapies depend on this anatomical knowledge.
Purpose of the Study:
- To provide historical perspective on angiographic aspects of liver-directed therapy.
- To discuss normal hepatic arterial anatomy, common variants, and perfusion changes in liver tumors.
- To optimize the safety and efficacy of liver-directed therapies using percutaneous techniques.
Main Methods:
- Review of angiographic literature and clinical experience.
- Analysis of normal hepatic arterial anatomy and common variants.
- Discussion of factors influencing regional hepatic perfusion in the presence of liver tumors.
Main Results:
- Hepatic arterial anatomy demonstrates high variability, impacting therapeutic interventions.
- Understanding regional hepatic perfusion is essential for optimizing drug delivery and treatment outcomes.
- Percutaneous techniques can enhance the safety and efficacy of transarterial liver therapies.
Conclusions:
- Detailed knowledge of hepatic arterial anatomy and perfusion is vital for successful liver-directed therapies.
- Anatomical variations require careful consideration for personalized treatment planning.
- This review synthesizes experience from over 500 transarterial liver-directed therapy cases.